We are live on ! Find out more
YF

Yu Fan Portfolio holdings

AUM $97M
1-Year Est. Return 57.2%
This Fund
S&P 500
This Quarter Est. Return
-24.5%
1 Year Est. Return
+57.2%
3 Year Est. Return
-14.37%
5 Year Est. Return
-61.92%
10 Year Est. Return
–
AUM
$8.85M
AUM Growth
-$29.5M
Cap. Flow
-$18.6M
Cap. Flow %
-209.65%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LUNG icon
Pulmonx
LUNG
+$13.9M
2
AVIR icon
Atea Pharmaceuticals
AVIR
+$4.69M

Sector Composition

Rank Sector Weight
1 Financials 55.52%
2 Healthcare 44.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABGI
1
DELISTED
ABG Acquisition Corp. I
ABGI
$4.91M 55.52%
501,300
– –
AVIR icon
2
Atea Pharmaceuticals
AVIR
$390M
$3.09M 34.92%
143,867
-156,133
-52% -$4.69M
SYRE icon
3
Spyre Therapeutics
SYRE
$8.7B
$780K 8.81%
4,482
– –
CRVO icon
4
CervoMed
CRVO
$28.5M
$66K 0.75%
1,198
– –
LUNG icon
5
Pulmonx
LUNG
$59.1M
– –
-303,030
Closed -$13.9M

Similar funds

PWM
Partners Wealth Management Carmel By The Sea, California $97M AUM 15.73% 1-Year Est. Return
ACM
Arrington Capital Management Miami, Florida $97.1M AUM
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $97.3M AUM 26.15% 1-Year Est. Return
SFO
Standard Family Office Sioux Falls, South Dakota $96.8M AUM 17.11% 1-Year Est. Return
CSW
Cogent Strategic Wealth Chicago, Illinois $97.3M AUM
TFS
truNorth Financial Services Chambersburg, Pennsylvania $96.7M AUM
FA
Fullerton Advisors Danville, California $96.6M AUM
JKSF
John & Kathleen Schreiber Foundation Lake Forest, Illinois $97.5M AUM 13.8% 1-Year Est. Return

Yu Fan's Q2 2021 Portfolio in Review

As of Q2 2021, Yu Fan held 5 positions worth $8.85M, down 77% from $38.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Yu Fan withdrew a net $18.6M in Q2 2021, closing 1 position and reducing 1 holding. Its most notable exit was Pulmonx, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 56% of assets, up from 13% a quarter earlier, followed by Healthcare.

  • Yu Fan's biggest Q2 2021 reduction was Atea Pharmaceuticals, cutting an estimated $4.69M.
  • Yu Fan fully exited Pulmonx in Q2 2021, selling an estimated $13.9M.
  • Yu Fan's ten largest holdings make up 100% of its $8.85M portfolio in Q2 2021.
  • Yu Fan opened 0 new positions and closed 1 in Q2 2021.
  • Yu Fan's portfolio value fell 77% quarter-over-quarter to $8.85M.

Based on Yu Fan's 13F filing for Q2 2021, filed 16 Aug 2021.